MIRM 8-K 2026-09-28
Mirum Pharmaceuticals, Inc. (MIRM) 8-K dated 2026-09-28 — accession 0001759425-26-000049.
Mirum Pharmaceuticals, Inc. (MIRM) is a biotechnology company listed on NASDAQ.
Mirum Pharmaceuticals, Inc. filed a 8-K on 2026-09-28. Accession 0001759425-26-000049.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.
Not investment advice. The MIRM SEC hub lists recent forms. The stock page is the research view.